<!doctype html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta name="viewport" content="width=device-width, initial-scale=1"/>
<title>I003 — Fort Carson Fire and EMS – Prehospital Practice Guidelines</title>
<style>
:root{--bg:#0b1220;--panel:#111a2e;--text:#e8eefc;--muted:#9fb0d0;--accent:#4ea1ff;}
*{box-sizing:border-box}
body{margin:0;font-family:system-ui,-apple-system,Segoe UI,Roboto,Arial,sans-serif;background:var(--bg);color:var(--text);}
a{color:var(--accent);text-decoration:none}
a:hover{text-decoration:underline}
.layout{display:grid;grid-template-columns:320px 1fr;min-height:100vh}
.sidebar{background:var(--panel);padding:16px;overflow:auto;border-right:1px solid rgba(255,255,255,.08)}
.main{padding:20px;max-width:1100px}
h1,h2,h3{margin:0.6em 0}
.small{color:var(--muted);font-size:0.9rem}
.searchbox{display:flex;gap:8px;margin:12px 0}
input[type="search"]{width:100%;padding:10px 12px;border-radius:10px;border:1px solid rgba(255,255,255,.15);background:rgba(0,0,0,.25);color:var(--text)}
button{padding:10px 12px;border-radius:10px;border:1px solid rgba(255,255,255,.15);background:rgba(78,161,255,.15);color:var(--text);cursor:pointer}
button:hover{background:rgba(78,161,255,.22)}
.nav-section{margin-top:14px}
.nav-section-title{font-weight:700;margin:8px 0 6px}
.nav-list{list-style:none;padding:0;margin:0;display:flex;flex-direction:column;gap:6px}
.nav-list a{display:block;padding:8px 10px;border-radius:10px;background:rgba(255,255,255,.04)}
.nav-list a:hover{background:rgba(255,255,255,.08)}
.card{background:rgba(255,255,255,.04);border:1px solid rgba(255,255,255,.08);border-radius:16px;padding:14px;margin:12px 0}
pre{white-space:pre-wrap;word-wrap:break-word;background:rgba(0,0,0,.25);padding:12px;border-radius:14px;border:1px solid rgba(255,255,255,.08);overflow:auto}
details{margin-top:10px}
img.page-scan{width:100%;height:auto;border-radius:12px;border:1px solid rgba(255,255,255,.12);background:#0a0f1b}
.topbar{display:flex;justify-content:space-between;align-items:center;gap:12px}
.badge{display:inline-block;padding:4px 10px;border-radius:999px;background:rgba(78,161,255,.15);border:1px solid rgba(78,161,255,.35);font-size:.85rem;color:var(--text)}
.results{display:flex;flex-direction:column;gap:10px}
.result{padding:12px;border-radius:14px;background:rgba(255,255,255,.04);border:1px solid rgba(255,255,255,.08)}
.result-title{font-weight:700}
.result-meta{color:var(--muted);font-size:.9rem;margin-top:4px}
</style>

</head>
<body>
<div class="layout">
  <aside class="sidebar">
    <div class="topbar"><div><div style="font-weight:800;line-height:1.1">Fort Carson Fire and EMS – Prehospital Practice Guidelines</div><div class="small">GitHub Pages site</div></div></div>
<div class="searchbox"><input id="q" type="search" placeholder="Search guidelines… (e.g., A007, trauma, ketamine)" aria-label="Search"><button id="go">Search</button></div>
<div class="small">Tip: click a guideline on the left, or use search.</div>
<div class="nav-section"><div class="nav-section-title">General Guidelines</div><ul class="nav-list">
<li><a href="A001.html">A001 — Guideline Key</a></li>
<li><a href="A002.html">A002 — well as documentation.</a></li>
<li><a href="A003.html">A003 — Decision Making Capacity</a></li>
<li><a href="A004.html">A004 — completed.</a></li>
<li><a href="A005.html">A005 — care with some situational specifics.</a></li>
<li><a href="A006.html">A006 — Benzodiazapines are an exception to the above statement</a></li>
<li><a href="A007.html">A007 — Trauma Criteria</a></li>
<li><a href="A008.html">A008 — the provider should, when in doubt, attempt resuscitation.</a></li>
<li><a href="A009.html">A009 — Definition of Abuse</a></li>
<li><a href="A011.html">A011 — OVERSIGHT</a></li>
<li><a href="A012.html">A012 — “CHAPTER TWO ‐ RULES PERTAINING TO EMS PRACTICE AND MEDICAL DIRECTOR OVERSIGHT”</a></li>
<li><a href="A015.html">A015 — Military Police (MP’s)</a></li>
<li><a href="A014.html">A014 — illness.</a></li>
</ul></div>
<div class="nav-section"><div class="nav-section-title">Procedures</div><ul class="nav-list">
<li><a href="B001.html">B001 — Provider</a></li>
<li><a href="B002.html">B002 — Definition:</a></li>
<li><a href="B003.html">B003 — All medications in this guideline will be given by standing order</a></li>
<li><a href="B004.html">B004 — Descriptions</a></li>
<li><a href="B005.html">B005 — during transport.</a></li>
<li><a href="B006.html">B006 — with a suspected cervical spine injury.</a></li>
<li><a href="B007.html">B007 — Provider Level</a></li>
<li><a href="B008.html">B008 — Provider Level</a></li>
<li><a href="B009.html">B009 — Provider Level</a></li>
<li><a href="B010.html">B010 — Extremity Splinting</a></li>
<li><a href="B011.html">B011 — Orogastric Tube Insertion</a></li>
<li><a href="B012.html">B012 — Special Considerations</a></li>
</ul></div>
<div class="nav-section"><div class="nav-section-title">Respiratory Emergencies</div><ul class="nav-list">
<li><a href="C001.html">C001 — designed to create a simplified and standard treatment algorithm.</a></li>
<li><a href="C002.html">C002 — ALBUTEROL NEB; PRN every 10 minutes</a></li>
<li><a href="C003.html">C003 — YES</a></li>
<li><a href="C004.html">C004 — Suspected Cause</a></li>
</ul></div>
<div class="nav-section"><div class="nav-section-title">Cardiac Emergencies</div><ul class="nav-list">
<li><a href="D001.html">D001 — STEMI</a></li>
<li><a href="D002.html">D002 — TRANSCUTANEOUS</a></li>
<li><a href="D003.html">D003 — Initial assessment</a></li>
<li><a href="D004.html">D004 — General Electrotherapy</a></li>
<li><a href="D005.html">D005 — History and Presentation</a></li>
<li><a href="D006.html">D006 — Special Considerations</a></li>
<li><a href="D007.html">D007 — ventricular dysfunction.</a></li>
<li><a href="D004.html">D004 — goal is 35 to 45 mmHg avoid hyperventilation to achieve.</a></li>
</ul></div>
<div class="nav-section"><div class="nav-section-title">Medical Emergencies</div><ul class="nav-list">
<li><a href="E001.html">E001 — Suicidal Ideation Assessment Tool</a></li>
<li><a href="E002.html">E002 — Stroke Screening</a></li>
<li><a href="E003.html">E003 — Establish vascular access, if possible</a></li>
<li><a href="E004.html">E004 — guidelines”.</a></li>
<li><a href="E005.html">E005 — Special Considerations</a></li>
<li><a href="E006.html">E006 — YES</a></li>
<li><a href="E007.html">E007 — General supportive care</a></li>
<li><a href="E008.html">E008 — Special Considerations</a></li>
<li><a href="E009.html">E009 — thighs upward and apply gentle open hand pressure above the pubic bone.</a></li>
<li><a href="E010.html">E010 — a. If suspected trauma evaluate for septal hematoma</a></li>
<li><a href="E003.html">E003 — Special Considerations</a></li>
</ul></div>
<div class="nav-section"><div class="nav-section-title">Traumatic Emergencies</div><ul class="nav-list">
<li><a href="F001.html">F001 — Traumatic injuries require prompt care and transportation.</a></li>
<li><a href="F002.html">F002 — Special Considerations</a></li>
<li><a href="F003.html">F003 — b. If stable consider pain management, see PAIN MANAGEMENT GUIDELINE</a></li>
<li><a href="F004.html">F004 — splinting to avoid impeding vascular drainage</a></li>
<li><a href="F005.html">F005 — b. If stable consider pain management, see PAIN MANAGEMENT GUIDELINE</a></li>
<li><a href="F006.html">F006 — If stable, consider pain management, see PAIN MANAGEMENT GUIDELINE</a></li>
<li><a href="F007.html">F007 — GUIDELINE</a></li>
<li><a href="F008.html">F008 — a. Drowning and near drowning refer to submersion injuries.</a></li>
<li><a href="F009.html">F009 — If ROSC is NOT achieved consider Termination of Resuscitation</a></li>
<li><a href="F010.html">F010 — renal failure, cardiac dysrhythmias, and death.</a></li>
<li><a href="F011.html">F011 — necrosis and thus the extra‐ esophageal structures at highest risk of injury.</a></li>
</ul></div>
<div class="nav-section"><div class="nav-section-title">Environmental Emergencies</div><ul class="nav-list">
<li><a href="G001.html">G001 — Initial assessment</a></li>
<li><a href="G002.html">G002 — appropriate facility</a></li>
<li><a href="G003.html">G003 — Initial assessment</a></li>
<li><a href="G004.html">G004 — Rewarm extremity</a></li>
</ul></div>
<div class="nav-section"><div class="nav-section-title">Medications</div><ul class="nav-list">
<li><a href="H000.html">H000 — Approved Medication and Routes</a></li>
<li><a href="H035.html">H035 — Provider Level</a></li>
<li><a href="H001.html">H001 — Provider Level</a></li>
<li><a href="H002.html">H002 — Provider Level</a></li>
<li><a href="H003.html">H003 — Provider Level</a></li>
<li><a href="H004.html">H004 — Provider Level</a></li>
<li><a href="H005.html">H005 — Provider Level</a></li>
<li><a href="H007.html">H007 — Provider Level</a></li>
<li><a href="H008.html">H008 — Provider Level</a></li>
<li><a href="H009.html">H009 — Provider Level</a></li>
<li><a href="H011.html">H011 — Provider Level</a></li>
<li><a href="H012.html">H012 — Provider Level</a></li>
<li><a href="H036.html">H036 — Provider Level</a></li>
<li><a href="H013.html">H013 — Epinephrine (1:1,000) IM</a></li>
<li><a href="H014.html">H014 — Provider Level</a></li>
<li><a href="H015.html">H015 — Condition</a></li>
<li><a href="H016.html">H016 — Provider Level</a></li>
<li><a href="H017.html">H017 — Provider Level</a></li>
<li><a href="H006.html">H006 — Provider Level</a></li>
<li><a href="H018.html">H018 — Provider Level</a></li>
<li><a href="H019.html">H019 — Waivered Medication</a></li>
<li><a href="H042.html">H042 — Provider Level</a></li>
<li><a href="H039.html">H039 — Condition</a></li>
<li><a href="H020.html">H020 — Condition</a></li>
<li><a href="H011.html">H011 — Provider Level</a></li>
<li><a href="H022.html">H022 — Provider Level</a></li>
<li><a href="H024.html">H024 — Route</a></li>
<li><a href="H025.html">H025 — Route</a></li>
<li><a href="H026.html">H026 — Provider Level</a></li>
<li><a href="H027.html">H027 — Provider Level</a></li>
<li><a href="H023.html">H023 — Provider Level</a></li>
<li><a href="H028.html">H028 — Waivered Medication</a></li>
<li><a href="H029.html">H029 — Provider Level</a></li>
<li><a href="H030.html">H030 — Waivered Medication</a></li>
<li><a href="H031.html">H031 — Provider Level</a></li>
<li><a href="H037.html">H037 — Waivered Medication</a></li>
<li><a href="H032.html">H032 — Provider Level</a></li>
<li><a href="H033.html">H033 — Waivered Medication</a></li>
</ul></div>
<div class="nav-section"><div class="nav-section-title">Special Situations</div><ul class="nav-list">
<li><a href="I001.html">I001 — LAD = left anterior descending</a></li>
<li><a style="outline:2px solid rgba(78,161,255,.35)" href="I003.html">I003 — MAINTENANCE OF IV INFUSIONS AND DEVICES</a></li>
</ul></div>
<div class="nav-section"><div class="nav-section-title">Infectious Disease</div><ul class="nav-list">
<li><a href="K001.html">K001 — during the event.</a></li>
<li><a href="K003.html">K003 — YES</a></li>
</ul></div>
<div class="nav-section"><div class="nav-section-title">Extras</div><ul class="nav-list">
<li><a href="../index.html">Search</a></li>
<li><a href="about.html">About / How this site was built</a></li>
</ul></div>
  </aside>
  <main class="main">
    
<h1>I003 — MAINTENANCE OF IV INFUSIONS AND DEVICES</h1>
<div class="small">Special Situations • Pages 146-152</div>
<div class="card">
  <div class="small">Use the scanned pages to see the official tables/charts/algorithms. The extracted text is there for copy/paste and searchability.</div>
</div>
<h3>Extracted text (page 146)</h3><pre>I003 Revised: 5/11/2022 
 
MAINTENANCE OF IV INFUSIONS AND DEVICES 
a. Purpose 
 
A patient that is being treated at one medical facility and requires ground transportation to another 
medical facility should not suffer from a change in the standard of care during transport. The orderly 
transfer of patients between medical facilities is provided for under the INTERHOSPITAL TRANSFER 
protocol. This addendum is meant to allow for the maintenance of certain intravenous infusions and 
devices during the course of the transfer. 
 
It is not possible to foresee all possible interventions that a patient may be undergoing at the time of such 
a transfer, however, the following considerations should be kept in mind: 
 
The overall status of the patient should direct the resources that are used for the transfer. If the patient is 
critically ill or injured, a nurse, paramedic or physician that is familiar with the patient should accompany 
you during transport. If the patient “crashes” it is worth having an extra pair of hands available. 
i. In the presence of a medication, procedure or device that is new to the patient (and that you 
are unfamiliar with), you should have a nurse or physician that is familiar with the patient 
accompany you during transport. 
ii. In the presence of a medication, procedure or device that is not new to the patient you may 
attend the patient without assistance if: 
1. No complications are anticipated, and; 
2. You can be familiarized with the medication, procedure or device before departure 
from the sending facility, and; 
3. Written orders from the sending physician are obtained or 
4. The patient is used to controlling the medication, procedure or device on their own, are 
currently capable of doing so, and the continuation of such has been approved by the 
physician who is attending to the patient. 
iii. When in doubt, ask for help. Contact the base hospital physician with any concerns BEFORE you 
encounter problems, if at all possible. 
 
b. General Procedures 
 
 The following apply to each of the medications covered in this protocol. 
i. Administration of these medications may not be initiated by EACH paramedics, unless covered 
elsewhere in the protocols. 
ii. If the medication is to be infused via an infusion pump, you must be familiar with the operation 
of that particular pump or have a nurse accompany the patient during transport. 
iii. You are responsible for the patency of the intravenous line. 
iv. Know the concentration of the drug solution and follow the infusion rate that was ordered by 
the treating physician. 
v. Document the concentration, the infusion rate, and the total infusion amount in the prehospital 
report. 
vi. If infiltration occurs during infusion, discontinue immediately and contact the base hospital 
physician. 
vii. If any adverse reactions occur during infusion, discontinue immediately and contact the base 
hospital physician. 
viii. If you feel that you require assistance during transport, get assistance.</pre><h3>Extracted text (page 147)</h3><pre>I003 Revised: 5/11/2022 
c. 
Approved for Paramedic Level Transport 
 
Medications 
Skills 
Activated Charcoal 
Magnesium sulfate 
Chest tube monitoring 
Adenosine 
Mannitol 
Ventilators (ATV) 
 
Restricted to 
manipulation 
of tidal volume, 
respiratory 
rate, FiO2, and 
Peep ONLY 
Albuterol/Xopenex 
Methylprednisolone 
Amiodarone 
Metoclopramide 
Antibiotics 
Metaproterenol 
Aspirin 
Midazolam 
Atropine 
Morphine 
Benzocaine spray 
Narcan 
Blood products 
Nerve agent antidotes 
 
Bumetanide 
Nicardipine 
 
Calcium 
Nitroglycerin 
 
Colloids 
Nitrous oxide 
 
Crystalloids 
Octreotide 
 
Cyanide antidote 
Olanzapine 
 
Dexamethasone 
Ondansetron 
 
Diazepam 
Over‐the‐counter medications 
 
Diltiazem 
Oxytocin 
 
Diphenhydramine 
Pantoprazole 
 
Dopamine 
Potassium 
 
Droperidol 
Pralidoxime 
 
Epinephrine 
Promethazine 
 
Fentanyl 
Racemic epinephrine 
 
Furosemide 
Rocuronium(MAAM waivered paramedics only) 
 
Glucagon 
Sodium bicarbonate 
 
Glycoprotein inhibitors 
Terbutaline 
 
Haloperidol 
Tetracaine 
 
Heparin 
Thiamine 
 
Hydrocortisone 
Topical hemostatic agent 
 
Hydromorphone 
TPN 
 
Insulin 
Vasopressin 
 
Ipratropium 
Vecuronium (MAAM waivered paramedics only) 
 
IV dextrose 
Verapamil 
 
Ketamine (pain/sedation) 
Ziprasidone 
 
Lidocaine 
Any medication authorized in guidelines 
 
Lorazepam 
 
 
Low molecular weight 
heparin</pre><h3>Extracted text (page 148)</h3><pre>I003 Revised: 5/11/2022 
d. Registered Nurse or Physician Required During Transport 
 
Thrombolytics 
 
Propofol Infusion 
 
Arterial lines (if actively in use) 
 
Portable ventilators (that fall outside of above parameters of manipulation) 
 
Balloon pumps 
 
Transvenous pacing 
 
Intracranial monitoring 
 
Pericardiocentesis 
 
Any other medication, device, or procedure not included in Ch2 scope, in the above list in Section III, or 
with which you are not familiar. 
 
Any concern that you need additional expertise available during transport 
 
Attachments for Specific Procedures and Precautions for Paramedic Level Approved Transports 
a. HEPARIN 
 
Indications: Intravenous heparin is frequently administered as an anticoagulant to prevent clotting in the 
setting of ischemic coronary artery disease, pulmonary embolism, or peripheral vascular conditions. 
 
Mechanism of Action: inhibits the mechanisms of blood clotting and formation of fibrin clots by 
inactivation of activated Factor X and inhibition of prothrombin’s conversion to thrombin 
 
Contraindications: Severe thrombocytopenia and active bleeding 
 
Complications: Hemorrhage from any site may occur, as well as, hypersensitivity signs and symptoms. 
Hypotension may also occur during infusion. If any complication occurs during infusion, discontinue 
infusing the medication and contact base hospital physician. 
 
Procedure: Usually 20,000 or 40,000 units of heparin are added to 1,000 cc of normal saline. The 
administration is dependent upon the patient’s weight. The usual infusion is 12‐18 units/kg/hr 
depending on the indications. Maintain the infusion rate that was ordered by the treating physician. 
 
b. NITROGLYCERIN 
 
Indications: Nitroglycerin administration results in smooth muscle relaxation and consequential 
dilatation of peripheral arteries and veins. These results in pooling of blood decreased left ventricular 
end‐diastolic wedge pressure (preload), and coronary artery dilatation. These mechanisms are useful in 
treating ischemic coronary states and hypertension. 
 
Mechanism of Action: causes vasodilation that relieves tension on vascular smooth muscle and dilates 
peripheral veins and arteries 
 
Contraindications: Hypotension and shock may occur with even small amounts of nitroglycerin. Because 
of absorption of nitrates into plastic, the amount of drug exiting the IV tubing may be much less than the 
amount entering the tubing. There is no simple correction factor. The patient should be observed 
clinically for pain relief, blood pressure changes and signs of poor perfusion. The infusion rate should be 
adjusted accordingly, with Base Hospital approval. 
 
Procedure: 
i. Nitroglycerin is a concentrated drug that should be administered after dilution. Usual mixtures 
include 25‐50 mg in 500 cc of D5W or NS. This yields a solution of 50‐100 mcg / ml. 
ii. Discontinue the infusion and contact the Base Hospital physician if signs of poor perfusion 
(pallor, sweating, prolonged capillary refill, or decreased mental alertness) occur, or with systolic 
blood pressure less than 100 mmHg. 
iii. Infusion rates may be increased, only through direct contact with the Base Hospital physician, 
should the patient experience worsening ischemic chest pain or hypertension.</pre><h3>Extracted text (page 149)</h3><pre>I003 Revised: 5/11/2022 
c. 
ANTIBIOTICS 
 
Indications: Antibiotics may be given IV in serious or life‐ threatening infections to rapidly achieve high 
blood levels of the drug for maximum bacterial killing power. 
 
Contraindications: In general, the treating physician will have considered the contraindications to 
administration before the infusion is started. You should, however, review the patients’ previous allergy 
history. If a patient gives a history of an allergic reaction to the drug, the infusion should be discontinued 
and the Base Hospital should be notified immediately. 
 
Complications: If allergic signs or symptoms develop (e.g., itching, rash, difficulty breathing, wheezing, 
hypotension, etc.) discontinue the infusion immediately and notify the Base Hospital. Treat allergic 
reactions per protocol. Occasionally, local irritation at the IV site may develop. Discontinue the infusion 
and notify the Base Hospital if any complications occur. 
 
d. BLOOD and BLOOD PRODUCTS 
 
Indications: Blood or blood products administered intravenously may be lifesaving in hemorrhagic shock, 
certain anemic states, and other hematological disorders. The treating physician will have considered the 
indications prior to initiating the infusion. In general, you will be continuing the infusion of platelets or 
fresh‐frozen plasma for certain bleeding disorders. 
 
Contraindications: The treating physician will have considered the contraindications to blood transfusion. 
Some patients may object to the transfusion of blood products for religious reasons (i.e., Jehovah’s 
Witness). For problems, contact the Base Hospital. 
 
Complications: Transfusion reactions and hypersensitivity reactions can occur after the onset of blood 
product infusion. Symptoms may include restlessness, anxiety, flushing, chest or lumbar pain, 
tachycardia, tachypnea, nausea, and shock. Occasionally bleeding from coagulopathy may develop. If 
any of the signs or symptoms listed above develop after the initiation of the transfusion, the transfusion 
should be immediately discontinued and the Base Hospital contacted for instructions. Shock, if present, 
should be treated according to protocol. 
 
Procedure: 
i. Maintain infusion rates as indicated by the treating physician. 
ii. All blood products should be administered through tubing with a filter. 
iii. Document blood product number (with pen or sticker) to the permanent medical record and the 
trip sheet left at the receiving hospital. 
 
e. SOLUMEDROL / METHYLPREDNISOLONE 
 
Indications: Methylprednisolone is a potent anti‐inflammatory steroid that is used for a wide variety of 
conditions. Most frequently, you will encounter respiratory patients that have been placed on this 
medication for acute exacerbations of their chronic disease process. Occasionally, patients with 
neurologic sequelae secondary to a spinal cord injury will be placed on this medication in the hopes of 
preventing further injury to the cord by spinal edema. 
 
Mechanism of Action: A highly potent steroid with greater anti‐inflammatory activity than prednisolone 
and lesser tendency to induce sodium and water retention. 
 
Contraindications: Premature infants and patients with a known hypersensitivity to the drug. 
 
Precautions: Rare instances of bronchospasm, bradycardia, and other cardiac arrhythmias have been 
reported after large, rapid doses of intravenous methylprednisolone. 
 
Procedures: Maintain the infusion as it was directed by the treating physician. 
 
f. 
VITAMINS / TPN / ELECTROLYTES 
 
Indications: Intravenous vitamins or electrolytes may be infused when there is confirmed or suspected 
deficiencies that require correction.</pre><h3>Extracted text (page 150)</h3><pre>I003 Revised: 5/11/2022 
 
Contraindications: These will have been previously considered by the treating physician. 
 
Precautions: None with vitamins. Potassium (K+) should be given at the prescribed rate (usually no 
faster than 10 mg/hr). Infusion of intravenous potassium solutions may precipitate cardiac conduction 
abnormalities. All patients being given intravenous potassium must be on a cardiac monitor. The 
infusion rate must be watched very closely. 
 
Procedure: Maintain at prescribed rate with patient on a cardiac monitor (for potassium supplements). 
Infusion rate should be slowed if any burning or irritation occurs at the infusion site. Discontinue the 
infusion and contact the Base Hospital immediately if any complications, including arrhythmias, occur. 
 
g. INSULIN 
 
Indications: Insulin, a hormone that is normally produced by the pancreas, is required by the body for 
effective transport of glucose across cell membranes. Relative or absolute deficiencies in insulin can 
result in hyperglycemia, non‐ketotic hyperosmolar coma, or diabetic ketoacidosis. 
 
Mechanism of Action: Regulation of glucose metabolism by stimulating cellular uptake of glucose and 
inhibits glucose output from the liver 
 
Contraindications: Hypoglycemia or known allergy to naturally occurring (pork or beef products) 
products. 
 
Complications: The most frequent complication of exogenous insulin administration is hypoglycemia 
which may manifest by such symptoms as sweating, dizziness, restlessness, headache, anxiety, irritability, 
abnormal behavior, unsteady gait, slurred speech, blurred vision, personality changes, disorientation, 
unconsciousness, or seizures. Allergic reactions can produce swelling, itching, redness, hives, 
hypotension, diaphoresis, wheezing, difficulty breathing, or dysphagia. If any of these complications 
occur during infusion contact the Base Hospital and discontinue the infusion immediately. 
 
Procedure: 
i. The most common insulin drip is composed of Regular Humulin. The insulin drip should be 
prepared by the sending institution. A typical concentration is 50 units in 250 cc of NS (0.2 
units/ml). 
ii. Maintain drip rate as established by the treating physician. A typical loading dose for DKA is 0.1 
units/kg, followed by an infusion of 0.1 units/ kg/hr Monitor patient’s blood sugar during initial 
phase of transport and at least every 30 minutes thereafter. 
iii. In the setting of a patient with a beta blocker overdose this could be significantly higher dosing. 
iv. Monitor the patient for any changes in neurologic status or hemodynamic instability. 
 
h. OCTREOTIDE 
 
Indications: Esophageal Varices. 
 
Contraindications: Sensitivity to medication. 
 
Precautions: Not compatible with TPN, diazepam, or phenytoin. Severe hypoglycemia in diabetic 
patients. Prolonged QT syndrome. 
 
Procedure: Maintain drip at rate prescribed by physician. 
 
I. 
PANTROPRAZOLE 
 
Indications: Erosive esophagitis. 
 
Contraindications: Hypersensitivity to medication. 
 
Mechanism of Action: Proton pump inhibitor that suppresses the final step in gastric acid production and 
leads to inhibition of both basal and stimulated acid secretion 
 
Precautions: Do not co‐administer with other medications in the IV line. Dizziness and headache may be 
anticipated side effects 
 
Procedure: Maintain drip rate as prescribed. Do not give IV push.</pre><h3>Extracted text (page 151)</h3><pre>I003 Revised: 5/11/2022 
 
J. 
GLYCOPROTEIN INHIBITORS 
 
Indications: Acute coronary syndromes and PCI. 
 
Contraindications: These will have been previously considered by the treating physician. 
 
Precautions: Observe for any signs of bleeding, including intracranial. 
 
Procedure: Hypotension or signs of intracranial bleeding occur, immediately stop the infusion and 
contact medical control. 
 
k. 
NICARDIPINE 
 
Indications: Angina. Hypertensive crisis. 
 
Mechanism of Action: Calcium channel blocker that inhibits the transmembrane influx of calcium ions 
into the myocardium and selectively into coronary vascular smooth muscles without altering serum 
calcium concentrations 
 
Contraindications: Atrial fibrillation and flutter associated with accessory bypass tracts. High‐degree AV 
heart blocks (AVHB). Hypotension. Bradycardia. Cardiogenic shock. 
 
Precautions: Confusion, slurred speech, somnolence, hypotension, syncope, and bradycardia are all 
potential serious side effects of this medication. 
 
Procedure: Maintain at prescribed rate with patient on a cardiac monitor. Monitor blood pressure 
closely. 
 
l. 
OXYTOCIN 
 
Indications: Control of post‐partum bleeding. (NOTE ‐ If oxytocin is being used to induce labor, the 
patient should be accompanied by obstetrical personnel.) 
 
Mechanism of Action: Promotes uterine contractions by increasing intracellular concentrations of calcium 
in uterine myometrial tissue 
 
Contraindications: These will have been previously considered by the treating physician. 
 
Precautions: Tachycardia, PVC’s, hypotension and vomiting may be seen as side effects of this 
medication. 
 
Procedure: Maintain at prescribed rate in liter of normal saline. Consider second IV placement for fluid 
resuscitation purposes. 
 
l. 
MAGNESIUM 
 
Indications: (1) Tocolysis (often in conjunction with Beta‐agonist therapy), and (2) treatment of 
preeclampsia/eclampsia. 
 
Mechanism of Action: Exact mechanism unknown. Speculated that magnesium may decrease myometrial 
contractility 
 
Contraindications: These will have been previously considered by the treating physician. 
 
Precautions: Apnea, AV Block, Cardiac arrest and pulmonary edema may be seen as side effects of this 
medication. 
 
Procedure: Maintain at prescribed rate in liter of normal saline. Obtain baseline DTR’s and periodically 
re‐evaluate throughout transport (Note: diminished DTR’s tend to precede respiratory depression and 
AVHB). Consider second IV placement for fluid resuscitation and medication administration purposes. 
Calcium (under direct physician direction) may be utilized to reverse toxic effects of magnesium. 
 
l. 
AMIODARONE 
 Indications: Control of ventricular arrhythmias. Intravenous form of medication may occasionally be 
used for the control of atrial fibrillation.</pre><h3>Extracted text (page 152)</h3><pre>I003 Revised: 5/11/2022 
 Mechanism of Action: Antiarrhythmic with predominant class III effects of lengthening cardiac action 
potential and blocking myocardial potassium channels lead to slowed conduction and prolonged 
refractoriness. Also has sodium channel blockade, antisympathetic action and negative inotropy in nodal 
tissue. 
 Contraindications: Cardiogenic shock. Symptomatic bradyarrhythmias. 
 Precautions: Amiodarone may have significant proarrhythmic effects. These may be more pronounced in 
patients on other antiarrhythmic medications and antibiotic medications. Use in children and infants 
requires a pediatric specialty team for transport. 
 Procedure: Careful cardiac and hemodynamic monitoring is essential. Be particularly aware of 
prolonging QTc intervals as a harbinger of multiform ventricular tachycardia. Typical IV loading dose is 
 150 mg over 10 minutes. Maintenance drip is 0.5‐1 mg/min. Follow physician’s administration orders 
throughout transport. 
 
m. LIDOCAINE 
 Indications: Control of ventricular arrhythmias 
 Mechanism of Action: Antiarrhythmic that blocks sodium channels 
 Contraindications: These will have been previously considered by the treating physician. 
 Precautions: Cardiac arrhythmias due to proarrhythmic effects. Neurologic‐oriented side effects 
(including seizures) with overdosage. Discontinue infusion if patient becomes symptomatically 
bradycardic or develops AVHB. 
 Procedure: Maintain prescribed dosage regimen throughout transport. Typical drip rates range from 2‐4 
mg/min. 
 
n. KETAMINE 
 Indications: Sedation, Pain 
 Mechanism of Action: Rapid acting general anesthetic that produces analgesia 
 Contraindications: These will have been previously considered by the treating physician. 
 Precautions: Continuous cardiovascular monitoring. Hypertension and tachycardia are common side 
effects, however bradycardia and hypotension can occur. 
 Procedure: Maintain prescribed dosage regimen throughout transport. Typical drip rates range from 0.1‐
0.5mg/min. 
 
o. EPINEPHRINE 
 Indications: Hypotension, bradycardia, anaphylaxis 
 Contraindications: These will have been previously considered by the treating physician. 
 Mechanism of Action: Sympathomimetic catecholamine that acts on alpha and beta adrenergic receptors. 
 Precautions: Continuous cardiovascular monitoring required. May cause hypertension and 
tachydysrhythmias 
 Procedure: Maintain prescribed dosage regimen throughout transport. Typical drip rates range from 
0.05‐2mcg/kg/min 
 Indications: Treatment of hypotension and bradycardia</pre>
<details open>
  <summary><span class="badge">Scanned pages (tables/charts preserved)</span></summary>
  <div class="card"><div class="small">Page 146 scan</div><img class="page-scan" src="../assets/page-146.jpg" alt="Page 146 scan"></div><div class="card"><div class="small">Page 147 scan</div><img class="page-scan" src="../assets/page-147.jpg" alt="Page 147 scan"></div><div class="card"><div class="small">Page 148 scan</div><img class="page-scan" src="../assets/page-148.jpg" alt="Page 148 scan"></div><div class="card"><div class="small">Page 149 scan</div><img class="page-scan" src="../assets/page-149.jpg" alt="Page 149 scan"></div><div class="card"><div class="small">Page 150 scan</div><img class="page-scan" src="../assets/page-150.jpg" alt="Page 150 scan"></div><div class="card"><div class="small">Page 151 scan</div><img class="page-scan" src="../assets/page-151.jpg" alt="Page 151 scan"></div><div class="card"><div class="small">Page 152 scan</div><img class="page-scan" src="../assets/page-152.jpg" alt="Page 152 scan"></div>
</details>

  </main>
</div>
<script>
document.getElementById('go')?.addEventListener('click', ()=>{
  const q=document.getElementById('q').value.trim();
  if(!q) return;
  window.location.href = 'index.html?q=' + encodeURIComponent(q);
});
document.getElementById('q')?.addEventListener('keydown', (e)=>{
  if(e.key==='Enter') document.getElementById('go').click();
});
</script>
</body>
</html>